Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 190, Issue 1, Pages 231-239

出版商

The American Association of Immunologists

发表日期

2012-12-06

DOI

10.4049/jimmunol.1202645

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started